MedTrace Logo

Safety and Preliminary Efficacy Study of SA4503 in Subjects Recovering From Ischemic Stroke

NCT00639249 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2009-07-29

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and tolerability of SA4503 in patients recovering from a recent stroke. Secondary, to evaluate the efficacy of SA4503 compared to placebo.

Conditions

Interventions

DRUG

placebo

Oral administration

DRUG

SA4503 Low

Oral administration

DRUG

SA4503 High

Oral administration

Sponsors & Collaborators

  • M's Science Corporation

    lead INDUSTRY

Principal Investigators

  • Keith W Muir, MD · Southern General Hospital, Glasgow

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-02-29
Primary Completion
2009-06-30

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00639249 on ClinicalTrials.gov